Related references
Note: Only part of the references are listed.Methylnaltrexone for opioid-induced constipation in advanced illness
Jay Thomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Oxycodone
E Kalso
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
Opioids and the gut: pharmacology and current clinical experience
HU De Schepper et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2004)
Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans
P Holzer
NEUROSCIENCE LETTERS (2004)
Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy
CPN Watson et al.
PAIN (2003)
Controlled-release oxycodone for pain in diabetic neuropathy - A randomized controlled trial
JS Gimbel et al.
NEUROLOGY (2003)
Opioid-induced bowel dysfunction - Pathophysiology and potential new therapies
A Kurz et al.
DRUGS (2003)
Opioid antagonists: A review of their role in palliative care, focusing on use in opioid-related constipation
YS Choi et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Low-dose oral naloxone reverses opioid-induced constipation and analgesia
MW Liu et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Incidence, prevalence, and management of opioid bowel dysfunction
M Pappagallo
AMERICAN JOURNAL OF SURGERY (2001)
Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time
CS Yuan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Methylnaltrexone for reversal of constipation due to chronic methadone use - A randomized controlled trial
CS Yuan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Oral naloxone reverses opioid-associated constipation
W Meissner et al.
PAIN (2000)